FDA Pulls Unsafe Weight Loss Drug
The US health authorities have announced the withdrawal of the weight loss drug Lipofit Extreme 2.0 from the market due to its contamination with undisclosed harmful substances that pose health risks. Analyses revealed the presence of fluoxetine, a medication prescribed for depression and obsessive-compulsive disorder, in the morning tablets, and 2,4-Dinitrophenol (DNP), a toxic substance not approved for medical use, in the evening tablets. The combination of these two substances could lead to serious health dangers, including heart disorders, seizures, and sudden death, with symptoms such as nausea, vomiting, dizziness, and rapid heartbeat. The Food and Drug Administration (FDA) has urged consumers to stop using the product immediately and to avoid selling or transferring it due to the associated health risks.
Notice: This Is an AI-Generated Summary
Comments (0)